Here’s some reading for the weekend from our Twitter stream on @crossborderbio:
- RT @CVCACanada: Q1’10: venture-backed companies in Canada raised $166 million for 21 deals. $ 63M of that is in IT.Dow Jones via @startupcfo
- Friday Fun: check out this blog by the science advisor to The Big Bang Theory (best nerd sitcom ever)! http://bit.ly/bN25D7
- RT @JohnCFierce: Protox gets only $3M upfront in $75M Japan deal for BPH drug http://bit.ly/9lTn35 << I think the $5m “near term” counts too
- BELLUS Health (TSX $BLU) licenses AA amyloidosis product KIACTA(eprodisate) to Celtic Therapeutics. $10m up-front http://bit.ly/c8yYKH
- Ontario’s new $161m Life Sciences Strategy lead-in to #BIO2010 (incl $7m in emergency biotech funds, $114m to genomics) http://bit.ly/csQmgg
- RT @karls_mlab: My adventures this week in social media and the life sciences http://bit.ly/94Bm9l cites @Comprendia article at @genbio
- Therapure gets $4.2m BIP Grant from the Ontario Government. Congratulations! http://bit.ly/cXxmek << Is this the last of the BIPs?
- I’ll be there with @crossborderbio on! RT @Comprendia: Started a #BIO2010 twitter list, let me know if I’ve missed you! http://bit.ly/9kX2xb
- RT @dgmacarthur: Coverage from @genomicslawyer of test case for GINA – woman sues employer for BRCA2 discrimination: http://bit.ly/atNhRb
- New Ontario bioscience strategy TBA at 1pm presser tomorrow to lead into #BIO2010. Deets and links at crossborderbiotech.ca post-embargo.
- RT @mikesgene: President Announces Appointees for Bioethics Commission… http://ga.newsi.us/?x=11r
- FDA says you should have a “clear plan” developed on how to take “swift action” in case of cargo or warehouse theft. http://bit.ly/beIoCg
- @genomicslawyer @dgmacarthur Cost is part of the reason I think PGD will be major. Already big $ to do IVF, sequencing increment is small.
- @genomicslawyer @dgmacarthur agree prenatal will be huge, unless it’s lapped by preimplantation testing http://bit.ly/9RDOed
- Happy Birthday Takeda Canada! http://bit.ly/bgcMMg Previous coverage here http://bit.ly/cF7IUa
- RT @FierceBiotech: Merck plans to shutter three NJ R&D facilities. http://is.gd/bLJo0
- RT @CBCHealth: 9 die as virus found in B.C. hospital http://bit.ly/9dZYE9 << not H1N1, so far is all they know.
- RT @BiologyFool: $PFE is making bio-betters of Roche’s Rituxan amongst others WSJ: http://bit.ly/c66z4W
- RT @davidblerner: Harvard Business School Study Shows that Angel Investing is King http://bit.ly/cBXo70 << where “King” = p<0.05 ?
- Legal Matters Seminar, May 13: The New (Gene Patent) Economy. Details and to register – http://bit.ly/aGKOn8 9:14 AM Apr 27th via TweetDeck
- @WSJ VC Blog carries an interview with Index Ventures co-founder Neil Rimer on their new seed capital program http://bit.ly/b7raNN
- RT @Equicom: NEWS: YM BioSciences announces controlled equity offering. http://bit.ly/aH6QwS
- RT @jonmrich:The best pharma in social media? @JNJComm @pfizer_news @GSKUS @AstraZeneca or others? #Dosie Awards Voting http://bit.ly/b5BYfD
- Stay tuned for more before BIO.. RT @CLSD: Ontario supports genome projects: Invests $114.6 M in 8 research institutes..http://bit.ly/9K35dt
- Neovasc (TSX-V $NVC) sees 97% of warrants from 2009 financing exercised, nets $1.4m http://bit.ly/awAEGt
- OICR taking equity in 3 cos: new UHN spin-off for AML (Zhang), new Kelley-Sargent co with MaRS Innov, DVS Sciences http://bit.ly/d6pxlP
- RT @SternIR: Two new biotech IPOs ..Mon on Euronext: AB Science (TK inhibitor for pancreatic CA, GIST) & Deinove (biofuels & antiinfectives)
